Clinical manifestations and risk factors for oral immune reconstitution inflammatory syndrome in Mexico.

The immune reconstitution inflammatory syndrome (IRIS) is a rare acute complication presenting in people living with HIV (PLWH) within the first 6 months of starting combined antiretroviral therapy (cART). While there is relevant information about its pathogenesis and clinical spectrum, IRIS-oral lesions (IRIS-OLs) have been scarcely described. Thus, to establish the incidence and clinical characteristics of IRIS-OLs, data from a cohort of 158 HIV individuals starting cART, followed for 6 months, were obtained retrospectively. IRIS-OLs developed in 11.4% of the individuals, in a median time of 87.5 days, with oral candidiasis being the most frequent manifestation detected in eight individuals (5.1%). The study emphasizes the importance of the correct diagnosis and management of these lesions.

[1]  A. Tappuni,et al.  Systematic review of the changing pattern of the oral manifestations of HIV. , 2018, Journal of investigative and clinical dentistry.

[2]  P. Cornejo-Juárez,et al.  Clinical characteristics, predictors of immune reconstitution inflammatory syndrome and long-term prognosis in patients with Kaposi sarcoma , 2017, AIDS Research and Therapy.

[3]  A. Shet,et al.  The Epidemiology of IRIS in Southern India: An Observational Cohort Study , 2017, Journal of the International Association of Providers of AIDS Care.

[4]  R. Wilkinson,et al.  Immune reconstitution inflammatory syndrome in HIV-infected patients , 2015, HIV/AIDS.

[5]  L. Patton,et al.  Smoking as a risk factor for oral candidiasis in HIV-infected adults. , 2013, Journal of Oral Pathology & Medicine.

[6]  L. Haddow,et al.  Incidence, Clinical Spectrum, Risk Factors and Impact of HIV-Associated Immune Reconstitution Inflammatory Syndrome in South Africa , 2012, PloS one.

[7]  A. Sher,et al.  Selective expansion of polyfunctional pathogen-specific CD4(+) T cells in HIV-1-infected patients with immune reconstitution inflammatory syndrome. , 2012, Blood.

[8]  J. Chmiel,et al.  Immune reconstitution inflammatory syndrome: incidence and implications for mortality , 2012, AIDS.

[9]  A. Sher,et al.  Immune reconstitution inflammatory syndrome: the trouble with immunity when you had none , 2012, Nature Reviews Microbiology.

[10]  S. Flint,et al.  Clinical Markers of Immunodeficiency and Mechanism of Immune Reconstitution Inflammatory Syndrome and Highly Active Antiretroviral Therapy on HIV , 2011, Advances in dental research.

[11]  A. Tappuni.  Immune Reconstitution Inflammatory Syndrome , 2011, Advances in dental research.

[12]  G. Breton.  [Immune reconstitution inflammatory syndrome]. , 2011, Bulletin de l'Academie nationale de medecine.

[13]  J. Kaldor,et al.  Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy. , 2010, The Journal of infectious diseases.

[14]  M. Lederman,et al.  Risk Factor Analyses for Immune Reconstitution Inflammatory Syndrome in a Randomized Study of Early vs. Deferred ART during an Opportunistic Infection , 2010, PloS one.

[15]  Simon Wandel,et al.  Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis. , 2010, The Lancet. Infectious diseases.

[16]  A. Tappuni,et al.  Oral Kaposi sarcoma: a case of immune reconstitution inflammatory syndrome. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[17]  M. Ghannoum,et al.  The Oral HIV/AIDS Research Alliance: updated case definitions of oral disease endpoints. , 2009, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[18]  L. Samaranayake,et al.  Enhancement of Candida albicans Virulence After Exposition to Cigarette Mainstream Smoke , 2009, Mycopathologia.

[19]  G. Reyes-Terán,et al.  Identification of oral candidosis, hairy leukoplakia and recurrent oral ulcers as distinct cases of immune reconstitution inflammatory syndrome , 2009, International journal of STD & AIDS.

[20]  D. Boulware,et al.  Biomarkers of HIV Immune Reconstitution Inflammatory Syndrome. , 2008, Biomarkers in medicine.

[21]  P. Bohjanen,et al.  Immunopathogenesis of immune reconstitution disease in HIV patients responding to antiretroviral therapy , 2008, Current opinion in HIV and AIDS.

[22]  L. Gaitán-Cepeda,et al.  Oral Manifestations after Immune Reconstitution in HIV Patients on Haart , 2008, International journal of STD & AIDS.

[23]  Richard D Moore,et al.  Immune Reconstitution Inflammatory Syndrome: Risk Factors and Treatment Implications , 2007, Journal of acquired immune deficiency syndromes.

[24]  Matthew A. Meier,et al.  Immune reconstitution syndrome in HIV: validating a case definition and identifying clinical predictors in persons initiating antiretroviral therapy. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  S. Shelburne,et al.  Immune reconstitution inflammatory syndrome: more answers, more questions. , 2006, The Journal of antimicrobial chemotherapy.

[26]  E. Graviss,et al.  Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy , 2005, AIDS.

[27]  P. Price,et al.  Immune restoration disease after antiretroviral therapy , 2004, AIDS.

[28]  S. Shelburne,et al.  The immune reconstitution inflammatory syndrome. , 2003, AIDS reviews.

[29]  F. Bergmann,et al.  Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. , 2000, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[30]  M. French.  HIV/AIDS: immune reconstitution inflammatory syndrome: a reappraisal. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  Y. Jiménez Soriano,et al.  Oral lesions and immune reconstitution syndrome in HIV+/AIDS patients receiving highly active antiretroviral therapy. Epidemiological evidence. , 2008, Medicina oral, patologia oral y cirugia bucal.